Skip to main content
. 2025 Jun 7;18:2823–2838. doi: 10.2147/JPR.S486759

Table 3.

Summary of Health-Related Quality of Life (HRQoL) Scores (PROMIS Preference, PROPr) of DISTINCT CMM and SCS Treatments at Six months

DISTINCT SCS DISTINCT CMM
Baseline 6 Months Baseline 6 Months
Count 79 79 55 55
Mean (SD) 0.154 (0.094) 0.343 (0.155) a 0.152 (0.093) 0.162 (0.123) a
Median 0.139 0.302 0.143 0.142
[Min, Max] [−0.005, 0.399] [0.057, 0.742] [−0.005, 0.441] [−0.013, 0.609]

Notes: Authors’ calculations from the patient-level data collected using PROMIS-29+2 Profile v2.1 (PROPr) during DISTINCT trial. This table summarizes the Health-Related Quality of Life (HRQoL) metric derived from PROPr. The HRQoL metric ranges from 0 (as bad as dead) to 1 (perfect or ideal health). The mean HRQoL scores show a significant difference in the quality-of-life between patients in DISTINCT SCS vs DISTINCT CMM therapies at six months though the difference is marginal in the baseline between the two groups. a p < 0.001.

Abbreviations: CMM, Conventional Medical Management; PROMIS, Patient-Reported Outcome Measure Information System; SCS, Spinal Cord Stimulation; SD, Standard Deviation.